HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

COPD 2022

Ketevan Jugheli, Speaker at COPD congress 2022
Oral Presentation
Ketevan Jugheli, Akaki Tsereteli State University, Georgia

The results of treatment of patients with asthma / COPD largely depends on the level of the patients` education and the need to use of the recommended management plan, besides the availability of health care services and medicines. The role of the patient's education is impor [....] » Read More

Irine Pkhakadze, Speaker at COPD congress 2022
Oral Presentation
Irine Pkhakadze, Akaki Tsereteli State University, Georgia

The results of treatment of patients with asthma / COPD largely depends on the level of the patients` education and the need to use of the recommended management plan, besides the availability of health care services and medicines. The role of the patient's education is impor [....] » Read More

Tammie Fournier, Speaker at COPD congress 2022
Oral Presentation
Tammie Fournier, Allied Health, New Brunswick Community College, Canada

Globally, COPD impacts approximately 10% of the population and is the third leading cause of death. Pulmonary Rehabilitation (PR) is a gold standard intervention in the management of COPD developed to slow disease progression, reduce disabling symptoms, and overall improve the qu [....] » Read More

Tatyana Sarycheva, Speaker at COPD-2022
Oral Presentation
Tatyana Sarycheva, Masaryk University, Czech Republic

Background: Impaired lung function has been established as an independent predictor of mortality but there is less evidence on the mortality risk in persons with preserved lung function. We assessed the pattern of all-cause and cardiovascular mortality across the full distributio [....] » Read More

Robyn Palk, Speaker at COPD-2022 Congress
Oral Presentation
Robyn Palk, Allied Health, New Brunswick Community College, Canada

Globally, COPD impacts approximately 10% of the population and is the third leading cause of death. Pulmonary Rehabilitation (PR) is a gold standard intervention in the management of COPD developed to slow disease progression, reduce disabling symptoms, and overall improve the qu [....] » Read More

Lisa Curtis, Speaker at COPD-2022 Conferences
Oral Presentation
Lisa Curtis, Allied Health, New Brunswick Community College, Canada

Globally, COPD impacts approximately 10% of the population and is the third leading cause of death. Pulmonary Rehabilitation (PR) is a gold standard intervention in the management of COPD developed to slow disease progression, reduce disabling symptoms, and overall improve the qu [....] » Read More

Carlos Rivas Echeverria, Speaker at COPD-2022
Oral Presentation
Carlos Rivas Echeverria, The SLEEPCARE Clinics, United Kingdom

COVID-19 was declared as a pandemic in 2020, this could be the shortest pandemic in medical history due to the development of vaccines and proper social distancing and containing measurements. Therefore, the main pandemics of the XXI century are obesity, diabetes, hypertension, c [....] » Read More

Zhirong Zhang, Speaker at COPD Conference 2022
Oral Presentation
Zhirong Zhang, Université de Strasbourg, France

Inflammasome complexes are pivotal in the innate immune response to pathogens and other danger signals. The NLRP3 inflammasome is activated in response to a broad variety of cellular stressors, including COVID-19 infection. Most of the stimuli act in a potassium efflux-dependent [....] » Read More

Lyudmyla Kuyun, Speaker at  Pulmonology Conference
Oral Presentation
Lyudmyla Kuyun, Bogomolets National Medical University, Ukraine

Chronic Obstructive Pulmonary Disease (COPD) is a complex progressive lung inflammatory disease accompanied by pathological changes in the large and small airways. COPD presents global concern due to its high mortality and has become the fourth leading cause of death in the world [....] » Read More

Shadi Hamoud, Speaker at COPD Congress-2022
Oral Presentation
Shadi Hamoud, Rambam Health Care Campus, Israel

Since DEC 2019 health authorities all over the world are in continuous combat against the Coronavirus disease 2019 (COVID-19) pandemic. The disaese was first described in Wuhan, China on DEC 2019, followed by rapid spread all over the world, and caused by the Coronovirus SARS-COV [....] » Read More

George E Chaux, Speaker at COPD congress 2022
Keynote Presentation
George E Chaux, Cedars Sinai Medical Center, United States

My presentation will focus on the current state of advanced surgical therapies available to treat patients with advanced emphysema/COPD. I will discuss surgical treatment options including bronchoscopic lung volume reduction, surgical lung volume reduction and lung transplantatio [....] » Read More

Daniela Cardoso, Speaker at COPD Conferences 2022
Poster Presentation
Daniela Cardoso, CHUC, Portugal

Introduction: The classification and management of COPD are currently based on a patient-centric approach, emphasising the importance of symptoms and exacerbation history (GOLD-classes). Since COPD patients present hight individual heterogeneity, the treatable traits (TT) strateg [....] » Read More

Hamid Mcheick, Speaker at COPD Congress
Oral Presentation
Hamid Mcheick, University of Quebec at Chicoutimi, Canada

Nowaday, ubiquitous health system is reshaping the research in the medical domain due to its potential to concurrently overcome the challenges encountered in the traditional healthcare systems. Prediction of exacerbation of Chronic Obstructive Pulmonary Disease (COPD) is consider [....] » Read More

Tszshan Ma, Speaker at COPD Conferences 2022
Oral Presentation
Tszshan Ma, Emory University, United States

RATIONALE: Risk of Chronic Obstructive Pulmonary Disease (COPD) and its disparities associated with air pollution exposures are less clear and warrant more evidence. OBJECTIVES: To examine the association between long-term exposure to air pollution and COPD incidence. METHO [....] » Read More

Liuhua Shi, Speaker at COPD Congress 2022
Oral Presentation
Liuhua Shi, Emory University, United States

RATIONALE: Risk of Chronic Obstructive Pulmonary Disease (COPD) and its disparities associated with air pollution exposures are less clear and warrant more evidence. OBJECTIVES: To examine the association between long-term exposure to air pollution and COPD incidence. METHO [....] » Read More

Siti Nur Fariza Nordin, Speaker at COPD-2022 Congress
Oral Presentation
Siti Nur Fariza Nordin, The Canberra Hospital, Australia

Background: There is a paucity of information regarding patients with COPD and hip fracture (HF), one of the most devastating diseases in the elderly. Objective: To explore in a large cohort of HF patients the prevalence of COPD, its clinical profile and impact on hospital out [....] » Read More

Jordan B Minov, Speaker at Pulmonology Congress 2022
Keynote Presentation
Jordan B Minov, Institute for Occupational Health, North Macedonia

Occupational exposures may cause new-onset asthma in a healthy subject, aggravate pre-existing asthma in a symptomatic individual or reactivate asthma in an asymptomatic individual. All these disorders are covered by the term work-related asthma (WRA) or work-attributable asthma, [....] » Read More

Piotr kusnierczyk, Speaker at COPD congress 2022
Keynote Presentation
Piotr kusnierczyk, Polish Academy of Sciences, Poland

  Immune eradication of cancer cells is dependent on polymorphisms of HLA class I molecules and antigen-processing machinery (APM) components, of which endoplasmic reticulum aminopeptidases 1 and 2 (ERAP1 and ERAP2) are most genetically polymorphic. We compared the distri [....] » Read More

Watsapp